Company profile: BTS Research
1.1 - Company Overview
Company description
- Provider of GLP, non-GLP, and cGMP biological and preclinical research services for pharmaceutical, biopharma, and academic clients, including in vitro clinical pathology, bioanalytical for small molecules and biologics, and cell-based functional assays; in vivo studies using validated disease models (cancer, inflammation, metabolic diseases); pharmacology (PK/PD), toxicology (acute to neurotoxicity), and SARS‑CoV‑2 neutralizing antibody assays in animal models.
Products and services
- In Vivo Services: Conducts GLP-compliant preclinical studies using various animal models to investigate biologics, inflammation, cancer, and metabolic diseases across relevant in vivo experimental designs
- In Vitro Services: Delivers GLP-capable clinical pathology services, bioanalytical testing for small molecules and biologics, and cell-based functional assays to support pharmaceutical product development
- Toxicology Services: Executes GLP-compliant acute, subchronic, chronic, and neurotoxicity studies to assess the safety and risk of substances in controlled preclinical settings
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BTS Research
Endeavor Clinical Trials
HQ: United States
Website
- Description: Provider of research and clinical trials specializing in surgical, orthopedic, and specialty medicine, based in San Antonio, Texas, with over 20 years of experience; one of 8 portfolio research units.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endeavor Clinical Trials company profile →
Alphora Research
HQ: Canada
Website
- Description: Provider of FDA-approved full-service CRDMO solutions focused on process chemistry, cGMP scale-up, and analytical method development for complex small-molecule APIs. Services include drug substance and product development for biologics and small molecules, preclinical and clinical outsourcing, CDMO manufacturing, and integrated end-to-end support from early development to full-scale manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alphora Research company profile →
Liberation Labs
HQ: United States
Website
- Description: Provider of industrial biotechnology infrastructure for agriculture, offering the Bio3 global precision fermentation platform, high-yield fermentation facilities, efficient fermentation processes with multiple feed capabilities and continuous sterilization, and downstream recovery using centrifugation, microfiltration and ultrafiltration to retain proteins and produce shelf-stable bioproducts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Liberation Labs company profile →
Arcus Medica
HQ: United States
Website
- Description: Provider of medical and scientific communications consulting services with full-service capabilities and expertise in oncology, hematology, transplant, and rare diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arcus Medica company profile →
Bioscript
HQ: United Kingdom
Website
- Description: Provider of regulatory consulting, product lifecycle support, and strategic medical communications services. Offerings include medical communications, market access consulting, regulatory writing, Bioscript Data Insights with tools like KOLNavigator, PubsNavigator and EventsNavigator, plus rare disease and oncology consulting covering strategy, engagement, communications, market access and regulatory writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioscript company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BTS Research
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BTS Research
2.2 - Growth funds investing in similar companies to BTS Research
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BTS Research
4.2 - Public trading comparable groups for BTS Research
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →